Streetbeat News

Products Services

CYBR

CyberArk has signed a definitive agreement to acquire Venafi from Thoma Bravo for an enterprise value of $1.54 billion. The acquisition will combine Venafi's machine identity management capabilities with CyberArk's identity security capabilities to create a unified platform for end-to-end machine identity security at enterprise scale. The deal will be financed with approximately $1 billion in cash and $540 million in CyberArk shares.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 11:02 am

JBI

Janus International Group, Inc. (NYSE:JBI) has announced the acquisition of Terminal Maintenance and Construction (TMC), a provider of terminal maintenance services for the trucking industry. The financial terms of the deal were not disclosed. This acquisition is expected to support the growth of Janus's Facilitate division.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:57 am

ANIP

ANI Pharmaceuticals has launched Kionex (Sodium Polystyrene Sulfonate Suspension USP) for oral or rectal use. The U.S. annual sales for this product total approximately $30.3 million, based on March 2024 moving annual total (MAT) IQVIA data.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:52 am

AAPL

Apple Inc. (NASDAQ:AAPL) has launched a significant discounting campaign for its iPhone models in China, offering discounts of up to $318. This move aims to counter increased competition from local rivals like Huawei. The campaign runs from May 20 to May 28 and follows a previous discounting effort in February. Despite challenges, some analysts remain optimistic about Apple's future in China.

Portfolio Pulse from Rounak Jain

May 20, 2024 | 10:46 am

STLA

VWAGY

XPEV

Volkswagen's Audi is partnering with SAIC to develop a new EV platform in China, aiming to accelerate its BEV portfolio and reduce time-to-market. This collaboration follows Volkswagen's $700 million investment in Xpeng and highlights the increasing reliance on Chinese technological expertise. Stellantis also announced a partnership with Leapmotor to bring models to Europe.

Portfolio Pulse from Shivani Kumaresan

May 20, 2024 | 10:42 am

ORCL

Oracle's $28 billion acquisition of Cerner's AI-driven health records system has backfired, leading to patient deaths and significant liabilities. The flawed EHR system has caused thousands of medical orders to disappear, resulting in three deaths. Despite these setbacks, Oracle is in talks with Elon Musk's xAI for a potential $10 billion deal to rent AI servers.

Portfolio Pulse from Benzinga Neuro

May 20, 2024 | 10:35 am

DYN

Dyne Therapeutics announced positive clinical data from its Phase 1/2 trials for DYNE-101 in Myotonic Dystrophy Type 1 and DYNE-251 in Duchenne Muscular Dystrophy. Both drugs showed significant improvements in key metrics and favorable safety profiles. The company is pursuing expedited approvals with updates expected by year-end.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:33 am

BW

Babcock & Wilcox Construction Co., a subsidiary of Babcock & Wilcox (NYSE:BW), has secured contracts worth over $20 million for power plant outage and rebuild work in the U.S.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:33 am

MNOV

MediciNova has received a Notice of Allowance from the US Patent and Trademark Office for its pending patent application covering MN-166 (Ibudilast) for the prevention of metastasis of eye cancer.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:04 am

GUTS

Fractyl Health, Inc. (NASDAQ:GUTS) presented preclinical data from its Rejuva pancreatic gene therapy program at Digestive Disease Week 2024, focusing on a single-administration GLP-1 therapy for obesity and type 2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 10:04 am